These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Target inhibition on GSK-3β by miR-9 to modulate proliferation and apoptosis of bladder cancer cells.
    Author: Dong ZC, Zhang D, Wang SB, Lin ZQ.
    Journal: Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3018-3026. PubMed ID: 29863246.
    Abstract:
    OBJECTIVE: Glycogen synthase kinase-3β (GSK-3β) can negatively regulate Wnt/β-catenin signaling pathway via degrading β-catenin protein, and plays suppressing roles in various tumors. Its role in bladder cancer pathogenesis is still unclear. In bladder cancer tissues, expression of microRNA-9 (miR-9) is significantly elevated. This study investigated the effect of miR-9 in modulating GSK-3β expression, Wnt/β-catenin pathway activity, and proliferation or apoptosis of bladder cancer cells. PATIENTS AND METHODS: Dual luciferase reporter gene assay confirmed targeted regulation between miR-9 and GSK-3β. Bladder cancer tissues were collected to measure expression of miR-9, GSK-3β mRNA using adjacent tissues as the control. Expression of miR-9 and GSK-3β was also measured in HBEC, RT4 and TCCSUP cells. Cultured RT4 and TCCSUP cells were transfected with miR-9 inhibitor or pSicoR-GSK-3β. The expression of miR-9, GSK-3β and β-catenin was compared, followed by using flow cytometry assay for cell apoptosis and EdU staining for cell proliferation. RESULTS: Comparing to adjacent tissues, bladder cancer tissues illustrated significantly elevated miR-9 expression and lower GSK-3β mRNA. Bioinformatics analysis revealed complementary binding sites between miR-9 and 3'-UTR of GSK-3β mRNA, indicating targeted regulation between miR-9 and GSK-3β. Comparing to HBEC cells, RT4 and TCCSUP cells had significantly elevated miR-9 expression and lower GSK-3β expression, with enhanced proliferation. Transfection of miR-9 inhibitor or pSicoR-GSK-3β significantly elevated GSK-3β expression and suppressed β-catenin expression, promoted cell apoptosis and inhibited proliferation. CONCLUSIONS: MiR-9 up-regulation plays a role in suppressing GSK-3β expression and facilitating bladder cancer pathogenesis. Inhibition of miR-9 could potentiate GSK-3β expression, suppress proliferation of bladder cancer, and facilitate apoptosis.
    [Abstract] [Full Text] [Related] [New Search]